Solid Therapeutics ApS is a Danish APS based in København N, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2022, the company has 3 employees and reported a gross profit of -DKK 1.7m in its latest annual filing.
EBITDA margin (of gross profit) 240.1 %
+44% vs 2024
Solidity ratio Equity ÷ Total assets × 100 Among the 10% lowest rated companies in the industry
2022 2025
Liquidity ratio Current assets ÷ Short-term debt Among the 20% highest rated companies in the industry
2022 2025
Return on assets (ROA) Net profit ÷ Total assets × 100 Among the 10% lowest rated companies in the industry
2022 2025
EBITDA — year on year DKK thousands 0 -2256 -4512 -6768 -9025 2022: -762 -762 2022 2023: -4193 (-450% vs 2022) -4193 -450% 2023 2024: -7247 (-73% vs 2023) -7247 -73% 2024 2025: -4052 (+44% vs 2024) -4052 +44% 2025
Key figures Annual report 2025 Gross profit -1.7M DKK -60% EBITDA -4.1M DKK +44% Net profit -4.4M DKK +36% Total assets 6.8M DKK -38% Equity -15.4M DKK -40% Employees 3 —
Legal name
Solid Therapeutics ApS
Founded
21 January 2022 · 4 years
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem eller af den samlede bestyrelse i forening.
Company purpose
Selskabets formål er at udøve aktiviteter indenfor fund af lægemidler og udvikling heraf.
(no translation available)
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Explore Financial development In its most recent annual report (2025), Solid Therapeutics ApS reported a gross profit of -DKK 1.7m. The figures on this page draw on 4 annual filings covering 2022 to 2025. The bottom line showed a net loss of DKK 4.4m.
At the end of 2025, current assets covered short-term debt 11.6 times. Solid Therapeutics ApS is one of 2 companies registered under Research and experimental development on natural sciences and engineering in Denmark.
Frequently asked questions What is the CVR number of Solid Therapeutics ApS? Solid Therapeutics ApS is registered with CVR / Virk under CVR 43007068.
What is the gross profit of Solid Therapeutics ApS? Solid Therapeutics ApS reported a gross profit of -DKK 1.7m in 2025.
How many employees does Solid Therapeutics ApS have? Solid Therapeutics ApS employs 3 people as of the latest annual report.
Who is the CEO of Solid Therapeutics ApS? John Sørensen Haurum is the CEO of Solid Therapeutics ApS, in role since 2025.
Who is the chairman of Solid Therapeutics ApS? John Sørensen Haurum chairs the board of Solid Therapeutics ApS.
Where is Solid Therapeutics ApS headquartered? Solid Therapeutics ApS's registered address is Ole Maaløes Vej 3.
More on Solid Therapeutics ApS 